SEC Filings

10-Q
MEDTRONIC PLC filed this Form 10-Q on 12/04/2017
Entire Document
 
Medtronic plc
Notes to Consolidated Financial Statements
(Unaudited)


The following tables provide a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis that used significant unobservable inputs (Level 3):
 
Three months ended October 27, 2017
(in millions)
Total Level 3
Investments
 
Corporate Debt
Securities
 
Auction Rate
Securities
July 28, 2017
$
45

 
$
1

 
$
44

Total unrealized gains (losses) included in other comprehensive income

 

 

October 27, 2017
$
45

 
$
1

 
$
44

 
 
 
 
 
 
 
Three months ended October 28, 2016
(in millions)
Total Level 3
Investments
 
Corporate Debt
Securities
 
Auction Rate
Securities
July 29, 2016
$
45

 
$
1

 
$
44

Total unrealized gains (losses) included in other comprehensive income

 

 

October 28, 2016
$
45

 
$
1

 
$
44

 
 
 
 
 
 
 
Six months ended October 27, 2017
(in millions)
Total Level 3
Investments
 
Corporate Debt
Securities
 
Auction Rate
Securities
April 28, 2017
$
45

 
$
1

 
$
44

Total unrealized gains (losses) included in other comprehensive income

 

 

October 27, 2017
$
45

 
$
1

 
$
44

 
 
 
 
 
 
 
Six months ended October 28, 2016
(in millions)
Total Level 3
Investments
 
Corporate Debt
Securities
 
Auction Rate
Securities
April 29, 2016
$
45

 
$
1

 
$
44

Total unrealized gains (losses) included in other comprehensive income

 

 

October 28, 2016
$
45

 
$
1

 
$
44

Activity related to the Company’s investment portfolio is as follows:
 
Three months ended
 
October 27, 2017
 
October 28, 2016
(in millions)
Debt(1)
 
Equity(2)
 
Debt(1)
 
Equity(2)
Proceeds from sales
$
1,383

 
$

 
$
2,444

 
$
76

Gross realized gains
11

 

 
57

 
25

Gross realized losses
(12
)
 

 
(37
)
 

Impairment losses recognized

 
(1
)
 

 
(7
)
 
 
 
 
 
 
 
 
 
Six months ended
 
October 27, 2017
 
October 28, 2016
(in millions)
Debt(1)
 
Equity(2)
 
Debt(1)
 
Equity(2)
Proceeds from sales
$
2,354

 
$

 
$
3,542

 
$
82

Gross realized gains
19

 
7

 
64

 
29

Gross realized losses
(15
)
 

 
(49
)
 

Impairment losses recognized

 
(1
)
 

 
(10
)
(1)
Includes available-for-sale debt securities and debt funds.
(2)
Includes marketable equity securities and cost and equity method investments.

14

X